trending Market Intelligence /marketintelligence/en/news-insights/trending/kIlfRRlfmxy2qXFOLT6Xrw2 content esgSubNav
In This List

German court dismisses Novartis appeal against Luye Pharma

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


German court dismisses Novartis appeal against Luye Pharma

The Court of Appeal for the district of Munich in Germany dismissed Novartis AG's appeal in a patent infringement lawsuit against Luye Pharma Group Ltd.'s Rivastigmine 1 day patch, a treatment for Alzheimer's disease.

Novartis also reimbursed the company of relevant legal expenses.